Presentation Handouts & ACPE Accreditation

ACPE Continuing Pharmacy Education
This program has been planned and implemented in accordance with the policies of the Accreditation Council on Pharmacy Education (ACPE) through the joint sponsorship of the Oregon State University College of Pharmacy and the Oregon Society of Health-System Pharmacists (OSHP). The Oregon State University College of Pharmacy is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians will receive ACPE Continuing Education Credit. An NABP e-Profile ID is required to receive CPE hours. An NABP e-Profile ID can be obtained at MyCPEMonitor.net. Statement of Credit shall be issued only after successful completion of the program. Successful completion is defined as: 1) Attending, in its entirety, the CPE activity or activities; 2) Participation in the pre-test administered by the presenter; 3) Completion of the online activity evaluation and post-test located at: http://pharmacy.oregonstate.edu/ce within 14 days of program attendance.

Statements of Credit will be uploaded to each participant’s NABP e-profile automatically within 48 hours of successful program completion. It is the participant’s responsibility to complete the online components within 14 days of program attendance to ensure awarding of credit. It is the participant's responsibility to check CPE Monitor and ensure credits have successfully uploaded.

Target Audience: Pharmacists and Pharmacy Technicians

Total Credits Available: 6 hours (0.6 CEUs)

Conflict of Interest Disclosures: None of the speakers or planners for this program have any financial relationships with ineligible companies to disclose.

Title: Evidence Based Review of Generalized Anxiety Disorders and Utilizing the Oregon Psychiatric Access Line (OPAL) for Support
UAN: 0036-9999-24-251-L01-P and 0036-9999-24-252-L01-T
Date & Time: 11/9/2024, 8:00-9:00 am
Speakers: Alana Ames, PharmD, BCPS, OHSU, Clinical Pharmacist; Jonathan Betlinksi, MD, George Saslow Professor of Psychiatry, OHSU
Audience: RPh and CPT
Activity-Type: Application-based for RPh, Knowledge-based for CPT
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

(RPh Only) Develop an evidence-based treatment plan for a patient newly presenting with an anxiety disorder
Identify at least 1 non-pharmacological treatment modality that can be used to improve anxiety symptoms
Describe the Oregon Psychiatric Access Line and what resources it provides to clinicians

Title: Inpatient Medicine: Cases in Antithrombotics and ID
UAN: 0036-9999-24-253-L01-P
Date & Time: 11/9/2024, 9:35-10:35 am
Speakers: Gregory B. Tallman, PharmD, MS, BCPS, BCIDP, Providence St. Vincent Medical Center, Clinical Pharmacy Specialist – Infectious Diseases; Jessie Dunne, PharmD, BCPS, BCCP, OHSU, Clinical Pharmacy Specialist – Cardiology
Audience: RPh
Activity-Type: Application-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

(Tallman) Summarize current treatment recommendations for infections caused by carbapenem-resistant Enterobacterales
(Tallman) Explain mechanisms of resistance to avibactam and cefiderocol among carbapenemase-producing Enterobacterales
(Tallman) Select appropriate antimicrobial therapy for patients with infections due to carbapenem-resistant Enterobacterales
(Dunne) Design an antithrombotic regimen for patients admitted for acute coronary syndrome
(Dunne) Implement and monitor an antithrombotic regimen for patients with valvular heart disease undergoing surgery

Title: Pharmacy Technician Panel Discussion: Non-Traditional Technician Roles (Tech Track)
UAN: 0036-9999-24-254-L99-T
Date & Time: 11/9/24, 9:35-10:35 am
Speakers:
Audience: CPT
Activity-Type: Application-based
Topic Designation: Additional Topic Areas
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

Discuss different pathways to becoming a technician
Explain how roles and experiences can shape non-traditional technician careers
Summarize the roles and responsibilities for non-traditional technician positions
Provide advice to aspiring technicians about the pathways to becoming a technician and the diverse opportunities available

Title: Getting Serious about CRS – Diving into the Specifics of Bispecifics
UAN: 0036-9999-24-255-L01-P
Date & Time: 11/9/2024, 10:55-11:55 am
Speakers: Catherine Chen, PharmD, BCOP, Hematology/Bone Marrow Transplant Clinical Pharmacist
Audience: RPh
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

Compare and contrast the different commercially available bispecific T-cell engager therapies available in the United States
Evaluate management strategies for complications that can arise bispecific T-cell engagers (including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome)
Discuss supportive care considerations relating to bispecific T-cell engagers
Explain how bispecific T-cell engagers are utilized in the treatment of various malignancies

Title: Technician Medication Management Panel (Tech Track)
UAN: 0036-9999-24-256-L04-T and 0036-9999-24-257-L04-T and 0036-9999-24-258-L06-T and 0036-9999-24-259-L02-T
Date & Time: 11/9/2024, 10:55-11:55 am
Speakers: Kelli Johnson, CPhT-Adv, PMP, CTDP, Pharmacy Stars – Implementation Specialist; Tony Montes de Oca, CPhT, Credena Health Medication Benefits Supervisor; Mercedes Edwards Post, CPhT, Credena Health LLC & Clinical Support Specialist and Pharmacy Technician
Audience: CPT
Activity-Type: Knowledge-based
Topic Designation: Additional Topic Areas
Credit Hours: 1.0 total (0.1 CEUs) (0.25 hrs each)
Learning Objectives:

(Johnson) Discuss advanced roles for pharmacy technicians, including opportunities in 340B analytics, 340B certification, and resources
(Montes de Oca) Identify various medication payment assistance programs and provide guidance on how to navigate these programs to help patients access necessary medications
(Edwards Post) Describe the essential knowledge and skills required for pharmacy technicians to safely and effectively administer immunizations
(Edwards Post) Review key principles of medication management for patients living with HIV

Title: Significant Clinical Trials You May Have Missed
UAN: 0036-9999-24-260-L01-P/T
Date & Time: 11/9/2024, 12:30-1:30pm
Speakers: Viet Nguyen, PharmD, BCPS, BCACP, MAD-ID, Northwest Medical Homes – Director of Pharmacy & PGY-2 Ambulatory Care Residency Program Director; Ben Vermillion, RPh, Legacy Health, Pharmacist
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

(Nguyen) Discuss the current recommendations on the use of doxycycline for post-exposure prophylaxis
(Nguyen) Review the DoxyPEP trial and how to apply to clinical practice
(Vermillion) Review the history of intermittent vs continuous infusion of beta-lactams
(Vermillion) Discuss how the findings of BLING III can be applied in clinical practice and broader policy discussions

Title: Pharmacologic Treatment of Opioid Use Disorder
UAN: 0036-9999-24-261-L08-P/T
Date & Time: 11/9/2024, 2:00-3:00 pm
Speakers: Kate Marshall, MD, FASAM, Chief of Service, Department of Addiction Medicine, Kaiser Permanente Northwest; Ehsan Seyedhossini, PharmD, Clinical Pharmacy Specialist, Kaiser Permanente
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Opioid/Pain Management/Substance Use Disorder
Credit Hours: 1.0 (0.1 CEUs)
RPh Learning Objectives:

Describe key moments in the history of pharmacologic treatment for opioid use disorder and the current regulatory status of methadone and buprenorphine
Name several clinical benefits of pharmacologic treatments for opioid use disorder
Differentiate between the mechanisms of action of methadone, buprenorphine, and naltrexone
Counsel a patient on safe and effective use of sublingual buprenorphine
Describe indications for providing a naloxone rescue kit

CPT Learning Objectives:

Describe key moments in the history of pharmacologic treatment for opioid use disorder and the current regulatory status of methadone and buprenorphine
Name several clinical benefits of pharmacologic treatments for opioid use disorder
Differentiate between the mechanisms of action of methadone, buprenorphine, and naltrexone

Title: OHA Health Equity Program Around Vaccination Efforts with Pacific Islanders in Oregon
UAN: 0036-9999-24-262-L06-P/T
Date & Time: 11/9/2024, 3:00-4:00 pm
Speakers: Melissa Anne Hanks, MA, OPMA, CPM, OHA Special Projects Manager; Rebecca Knight-Alvarez, MPH, BA, OHA, Senior Data & System Coordinator; Trevor Douglass, DC, MPH, OHA, Director, Pharmacy Policy & Programs; Michael Mon Fai Yu, DC, OHA, Community Pharmacy Liaison; Ronica Reimers, Citizen – Republic of the Marshall Islands, OHA, Language and Cultural Consultant; Alexandrea Mailo, Citizen - Federated States of Micronesia, OHA, Language and Cultural Consultant
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Immunizations (Cultural Competence)
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

Identify ways language, culture, and history contribute to population health and wellness disparities for this community
Assess the effectiveness of different team composition and interprofessional collaboration techniques in reaching this population and improving health outcomes
Describe how continuous quality improvement methods were used to recognize, assess, and navigate cultural and structural factors to improve access and health outcomes
Explain how language and communication barriers can create safety risks for effective medication use and patient care